Prednicarbate
Corticosteroids, Potent (Group Iii)
- Drug class
- Corticosteroids, Potent (Group Iii)
- Availability
- See label
- Routes
- Topical
- Markets covered
- 1
- Products on record
- 1
Overview
Prednicarbate is an active pharmaceutical ingredient in the Corticosteroids, Potent (Group Iii) group (D07AC). The information below is compiled per regulator from the product labels on record, with direct links to the original documents.
Regulatory status by market
| Market | Regulator | Products | Last revision |
|---|---|---|---|
| CA Canada | Health Canada | 1 | September 25, 2025 |
CACanada· Health Canada
1 product
Uses
1 Dosing Considerations 04/2022 7 WARNINGS AND PRECAUTIONS 04/2022 7 WARNINGS AND PRECAUTIONS, Endocrine and Metabolism 04/2022 TABLE OF CONTENTS Sections or subsections that are not applicable at the time of authorization are not listed.
RECENT MAJOR LABEL CHANGES ................................................................................... 2 TABLE OF CONTENTS .........................................................................................................
2 PART I: HEALTH PROFESSIONAL INFORMATION.............................................................. 4 1 INDICATIONS............................................................................................................. 1 Pediatrics ..........................................................................................................
2 Geriatrics........................................................................................................... 4 2 CONTRAINDICATIONS ..............................................................................................
Drug interactions
Known interactions involving Prednicarbate. Select one for details. This list is informational and not a complete interaction checker.
Interaction data compiled from DDInter (academic, CC-BY). Severity classification only - this is not a complete interaction checker and not medical advice.
Sources & citations
- [1]Health Canada (DPD) · 02230642 · revised September 25, 2025
Information on this page is compiled from public regulatory records. Drugvu is not affiliated with any regulator or pharmaceutical manufacturer. This is not medical advice. Always consult a qualified healthcare professional.